Amy Moore: Understanding the causes of cancer cachexia and finding new treatments
Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a post on LinkedIn about a recent paper by her and colleagues published in JCO Oncology Practice:
“I am proud to represent LUNGevity Foundation on the Cancer Grand Challenges Team CANCAN, which is working to understand the causes of and find new treatments for cancer cachexia.
In this new article, we also call attention to the barriers to proper diagnosis and coding, which hampers the ability to help patients impacted by this condition.”
“Call to Improve Coding of Cancer-Associated Cachexia”
Authors: Marcus Goncalves, Richard Dunne, Amy Moore, Wendy Phillips, Steven Heymsfield, Justin Brown, Erin Talbert, Tobias Janowitz.
More posts featuring Amy Moore.
Dr. Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science and Research at the Addario Lung Cancer Medical Institute (ALCMI).
She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023